High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer

被引:0
|
作者
Andreas H Marx
Claudius Mickler
Guido Sauter
Ronald Simon
Luigi M Terracciano
Jakob R Izbicki
Till S Clauditz
机构
[1] Institute of Pathology,Institute of Pathology
[2] University Medical Center Hamburg-Eppendorf,Institute of Pathology
[3] University Hospital Basel,Department of Surgery
[4] University Medical Center Hamburg-Eppendorf,undefined
关键词
Colorectal cancer; Intratumoral tumor budding; Prognosis; TMA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:259 / 268
页数:9
相关论文
共 50 条
  • [1] High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer
    Marx, Andreas H.
    Mickler, Claudius
    Sauter, Guido
    Simon, Ronald
    Terracciano, Luigi M.
    Izbicki, Jakob R.
    Clauditz, Till S.
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (02) : 259 - 268
  • [2] Tumor Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer
    Betge, Johannes
    Kornprat, Peter
    Pollheimer, Marion J.
    Lindtner, Richard A.
    Schlemmer, Andrea
    Rehak, Peter
    Vieth, Michael
    Langner, Cord
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (12) : 3706 - 3712
  • [3] Tumor Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer
    Johannes Betge
    Peter Kornprat
    Marion J. Pollheimer
    Richard A. Lindtner
    Andrea Schlemmer
    Peter Rehak
    Michael Vieth
    Cord Langner
    [J]. Annals of Surgical Oncology, 2012, 19 : 3706 - 3712
  • [4] Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin, Jung
    Ah Park, Yoon
    Wook Huh, Jung
    Hyeon Yun, Seong
    Cheol Kim, Hee
    Yong Lee, Woo
    Hyung Kim, Seok
    Yun Ha, Sang
    Cho, Yong Beom
    [J]. DISEASES OF THE COLON & RECTUM, 2023, 66 (08) : E801 - E808
  • [5] Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
    Serkan Zenger
    Bulent Gurbuz
    Ugur Can
    Ergin Erginoz
    Ibrahim Halil Ozata
    Serpil Postgil Yilmaz
    Orhun Cıg Taskin
    Onder Peker
    Volkan Adsay
    Emre Balik
    Dursun Bugra
    [J]. Langenbeck's Archives of Surgery, 408
  • [6] Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
    Zenger, Serkan
    Gurbuz, Bulent
    Can, Ugur
    Erginoz, Ergin
    Ozata, Ibrahim Halil
    Yilmaz, Serpil Postgil
    Taskin, Orhun Cig
    Peker, Onder
    Adsay, Volkan
    Balik, Emre
    Bugra, Dursun
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [7] Prognostic Value of the Lymphovascular Invasion in High-Grade Stage pT1 Bladder Cancer
    Branchereau, Julien
    Larue, Sebastien
    Vayleux, Bertrand
    Karam, Georges
    Bouchot, Olivier
    Rigaud, Jerome
    [J]. CLINICAL GENITOURINARY CANCER, 2013, 11 (02) : 182 - 188
  • [8] Lymphovascular invasion determines the outcome of stage I colorectal cancer patients
    Chang, Shih-Ching
    Lin, Chun-Chi
    Wang, Huann-Sheng
    Yang, Shung-Haur
    Jiang, Jeng-Kai
    Lan, Yuan-Tzu
    Lin, Tzu-Chen
    Li, Anna Fen-Yau
    Chen, Wei-Shone
    Lin, Jen-Kou
    [J]. FORMOSAN JOURNAL OF SURGERY, 2012, 45 (05) : 141 - 145
  • [9] A novel histologic grading system based on lymphovascular invasion, perineural invasion, and tumor budding in colorectal cancer
    Jung Wook Huh
    Woo Yong Lee
    Jung Kyong Shin
    Yoon Ah Park
    Yong Beom Cho
    Hee Cheol Kim
    Seong Hyeon Yun
    [J]. Journal of Cancer Research and Clinical Oncology, 2019, 145 : 471 - 477
  • [10] A novel histologic grading system based on lymphovascular invasion, perineural invasion, and tumor budding in colorectal cancer
    Huh, Jung Wook
    Lee, Woo Yong
    Shin, Jung Kyong
    Park, Yoon Ah
    Cho, Yong Beom
    Kim, Hee Cheol
    Yun, Seong Hyeon
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (02) : 471 - 477